Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS

This study has been completed.
Information provided by:
Boehringer Ingelheim Identifier:
First received: July 6, 2006
Last updated: May 18, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):